RICHC
AZN icon

Renaissance Investment Consultants Holding Company’s AstraZeneca AZN Stock Holding History

Renaissance Investment Consultants Holding Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$214K Buy
1,943
+8
+0.4% +$890 0.2% 76
2020
Q2 		$218K Buy
+1,935
New +$200K 0.24% 75

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Investment Consultants Holding Company's AZN Position: Q3 2020 in Review

Renaissance Investment Consultants Holding Company increased its AstraZeneca (AZN) stake by 0.41% in Q3 2020, buying an estimated $890 and bringing the position to 1,943 shares worth $214K. The position accounts for 0.2% of the portfolio, ranked #76.

Renaissance Investment Consultants Holding Company first reported a position in AZN in Q2 2020 and has held it in 2 quarters since. The position peaked at $218K in Q2 2020. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • Renaissance Investment Consultants Holding Company held 1,943 shares of AstraZeneca worth $214K as of Q3 2020.
  • Renaissance Investment Consultants Holding Company bought 8 AstraZeneca shares in Q3 2020, an estimated $890.
  • AstraZeneca made up 0.2% of Renaissance Investment Consultants Holding Company's portfolio in Q3 2020, its #76 holding.
  • Renaissance Investment Consultants Holding Company first reported a position in AstraZeneca in Q2 2020 and has held it in 2 quarters since.
  • Renaissance Investment Consultants Holding Company's AstraZeneca position peaked at $218K in Q2 2020.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Renaissance Investment Consultants Holding Company's 13F filing for Q3 2020, filed 6 Nov 2020.